UMass Lupus

@UMassLupus

Our research focuses on studying Lupus in hopes of providing patients with this devastating disease new treatment options.

Vrijeme pridruživanja: siječanj 2019.

Tweetovi

Blokirali ste korisnika/cu @UMassLupus

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @UMassLupus

  1. Prikvačeni tweet
    23. sij

    Teach them young 😉 Stop

    Poništi
  2. proslijedio/la je Tweet

    We set fiscal year NIAID Paylines as follows: ● R01 (non-new PIs): 14 percentile ● R01 (new PIs): 18 percentile ● R03: 31 overall impact score ● R21: 31 overall impact score Check our full list:

    Prikaži ovu nit
    Poništi
  3. proslijedio/la je Tweet
    28. sij
    , , i još njih 7
    Prikaži ovu nit
    Poništi
  4. proslijedio/la je Tweet
    27. sij

    . &co Synapse loss can occur early & prior to other -relevant pathology & is associated with synapse-localized complement C3. AAV approach to inhibit C3 protects synapses & preserves circuit function

    Prikaži ovu nit
    Poništi
  5. 27. sij
    Poništi
  6. 27. sij

    Curious to know if this happens in too we are working on it!

    Poništi
  7. proslijedio/la je Tweet
    26. sij

    NEW EULAR guidelines for RA, PMID 31969328 1. TtT! 🙏 2. MTX 1st line 🥰 3. More csDMARDs if no poor prognostic factors 🙄 4. Add bDMARD/JAKi if poor prognostic factors & csDMARD failure 🙂 5. IL6/JAKi if csDMARD not possible 👍 Overall good. I try HCQ but typically skip #3

    Poništi
  8. proslijedio/la je Tweet

    Learn, connect and advocate with the community at the nation's largest event, the LFA National Lupus Advocacy Summit. Your presence is crucial! Join us this March to help secure federal funding for and education.

    Poništi
  9. proslijedio/la je Tweet

    ., TY for using your platform to continue opening up & sharing your personal battle as a . By sharing these powerful words, you are helping educate others & raise awareness of autoimmune diseases like 💜 Read Carrie Ann's new blog about her journey.

    Poništi
  10. 24. sij

    Nice case report on using single cell RNA sequencing to inform JAK inhibitor therapy selection for DRESS syndrome by Kim et al from Nagao lab. (Our team is using this technology to study !)

    Poništi
  11. proslijedio/la je Tweet
    24. sij

    Ever shattered an orange using liquid nitrogen? That's how we get DNA out of ticks in our new article

    Prikaži ovu nit
    Poništi
  12. proslijedio/la je Tweet
    23. sij

    NEW podcast, anifrolumab for SLE. I cover TULIP-1 and TULIP-2 Interesting ?s, including multiple hypothesis testing, surrogate endpoints, and PROs. Let me know what you think after listening; share with friends! Subscribe at

    Poništi
  13. 23. sij

    Thank you for participating in , especially because this required your hand for venipuncture!!! 💜💪

    Poništi
  14. 23. sij
    Poništi
  15. proslijedio/la je Tweet
    23. sij

    It's out! Our JAKi study for inflammatory skin fibrosis! Awesome collaboration with and all the authors not yet on Twitter!

    Poništi
  16. proslijedio/la je Tweet
    22. sij

    David Guertin, PhD introducing MetNet for our researchers to share ideas and collaborate!

    Poništi
  17. proslijedio/la je Tweet

    Recent research from the about understanding tiny cells called microglia is mentioned in a new piece by

    Poništi
  18. proslijedio/la je Tweet
    21. sij

    If you identify as Black, have lupus, and would like to participate in biomedical lupus research please send me a DM.

    Poništi
  19. proslijedio/la je Tweet
    20. sij

    NEW ONLINE: Tofacitinib is associated with increased risk of admission to hospital for serious in patients with , including a 2-fold higher risk of compared to all bDMARDs

    Prikaži ovu nit
    Poništi
  20. proslijedio/la je Tweet
    19. sij

    When & how to use in ? What role can enteral nutrition, anti-inflammatory diet & other play in managing & modifying the gut ? Join us Jan 20 for w

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·